The reduction in VIP levels is likely to be beneficial because elevated VIP is considered to be a biomarker for an aggravated state of colonic inflammatory conditions, as seen in inflammatory bowel disease (IBD) [185,186]. This evidence concerns the gene VIP and inflammatory bowel disease.